Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

RARE PHOTOS: Verona pharma keeps hitting new highs - The Real Truth

Summary

  • Verona Pharma (VRNA) shows strong technical indicators with a 54.89% gain since 11/19, driven by Barchart's Trend Seeker buy signal.

  • The company focuses on developing ensifentrine for respiratory diseases, currently in Phase 3 trials, with multiple inhaler formulations.

  • Barchart's technical indicators highlight 100% buy signals, a 222.12% gain in the last year, and a Relative Strength Index of 71.94%.

  • Analysts' consensus targets a 12% gain, but MorningStar deems the stock 47% overvalued; diversification and stop-loss strategies are recommended.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.